Furthermore, we surprisingly found that inhibition of the PI3K/Akt/Nrf2 pathway was effective to suppress cell proliferation and stemness in the GBM cells cotreated with M2-CM, hinting that M2-CM promoted GBM aggressiveness through secreting VEGF. The gene discussed is AKT1; the disease is glioblastoma.